Gabriella Miller Kids First Common Fund Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, NEI, NHGRI, NHLBI, NIAAA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NINDS, OD/ DPCPSI/ ORIP
|
2015
|
|
Gastrointestinal Steering Committee Neuroendocrine Tumor Clinical Trials Planning Meeting: Treatment in the Rea of Peptide Receptor Radionuclide Therapy - March 8-9,2021
|
Meeting/ Workshop
|
FDA
|
NCI
|
2021
|
|
Gender Policy Council: HHS Women's Health & Rights Working Group
|
Committee, Advisory Group, or Work Group
|
SAMHSA, HRSA, CDC, OGA, OASH
|
NICHD
|
|
|
Genome in a Bottle Consortium (GIAB)
|
Resource Development
|
CDC, FDA
|
NHGRI, NCI
|
2013
|
|
Global Environmental and Occupational Health (GEOHealth)
|
Training Initiative
|
CDC
|
FIC, NCI, NIEHS, OD/ DPCPSI/ ORWH
|
2011
|
|
Global Health Security Agenda (GHSA) Action Package Prevent 3 (APP3), Biosafety and Biosecurity Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2014
|
|
Global Substance Registration System (GSRS)
|
Research Initiative
|
FDA
|
NCATS
|
2013
|
|
Government-University-Industry Research Roundtable (GUIRR)
|
Committee, Advisory Group, or Work Group
|
FDA
|
OD/ IMOD
|
|
|
Gynecologic Cancer Steering Committee Clinical Trials Planning Meeting: Defining and Targeting Molecular Pathways to Direct Personalized Value-added Treatments for Patients with Epithelial Ovarian Cancer - February 25-26, 2021
|
Meeting/ Workshop
|
FDA
|
NCI
|
2021
|
|